|
|
|
|
LEADER |
00000nam a2200000 i 4500 |
001 |
mig00005972197 |
003 |
OCoLC |
005 |
20210506132919.0 |
006 |
m o d f |
007 |
cr ||||||||||| |
008 |
210506s2021 dcu ol f000 0 eng c |
035 |
0 |
0 |
|a on1249948942
|
040 |
|
|
|a GPO
|b eng
|e rda
|e pn
|c GPO
|d MvI
|
042 |
|
|
|a pcc
|
043 |
|
|
|a n-us---
|
049 |
|
|
|a TXME
|
074 |
|
|
|a 0575-A-02 (online)
|
086 |
0 |
|
|a AE 2.110:117-9
|
088 |
|
|
|a Public Law 117-9
|
099 |
|
|
|a Online Government Document
|
110 |
1 |
|
|a United States,
|e enacting jurisdiction.
|
245 |
1 |
3 |
|a An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to the Scope of New Chemical Exclusivity.
|
264 |
|
1 |
|a [Washington, D.C.] :
|b [U.S. Government Publishing Office],
|c [2021]
|
300 |
|
|
|a 1 online resource (4 unnumbered pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
|
|
|a Description based on online resource; title from PDF title screen (govinfo web site, viewed on May 6, 2021).
|
500 |
|
|
|a "Apr. 23, 2021 (S. 415)."
|
500 |
|
|
|a "135 Stat. 256."
|
500 |
|
|
|a "Public Law 117-9."
|
650 |
|
0 |
|a Drug approval
|z United States.
|
650 |
|
0 |
|a Pharmaceutical policy
|z United States.
|
655 |
|
7 |
|a Statutes and codes.
|2 lcgft
|
856 |
4 |
0 |
|z CONNECT
|u https://purl.fdlp.gov/GPO/gpo155256
|t 0
|
907 |
|
|
|a 5428850
|b 07-01-21
|c 07-01-21
|
998 |
|
|
|a wi
|b 07-01-21
|c m
|d z
|e -
|f eng
|g dcu
|h 3
|i 1
|
910 |
|
|
|a MTSUM2106
|
910 |
|
|
|a DWS
|
956 |
4 |
0 |
|3 Text version
|u https://purl.fdlp.gov/GPO/gpo155257
|
999 |
f |
f |
|i 979c85d3-7597-42e5-a88d-b0c4d53e1a81
|s 2b6989ab-0ed0-47f0-bc78-0c2c48fde4ec
|t 0
|
952 |
f |
f |
|a Middle Tennessee State University
|b Main
|c James E. Walker Library
|d Electronic Resources
|t 0
|e AE 2.110:117-9
|h Library of Congress classification
|
856 |
4 |
0 |
|t 0
|u https://purl.fdlp.gov/GPO/gpo155256
|z CONNECT
|